Kristian Borbos
Fortune : 182 941 $ au 31/08/2026
Fortune : 182 941 $ au 31/08/2026
Kristian Borbos is currently Deputy Director at Ascelia Incentive AB and Chief Financial Officer at Gubra A since 2022.
Former roles include Chief Financial Officer at Ascelia Pharma AB from 2017 to 2022, Manager-Business Finance at Novozymes A from 2016 to 2017, and Lead Manager-Investor Relations at Ørsted A and Ørsted AB from 2009 to 2016.
Education includes graduate studies at the University of Lund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GUBRA A/S 0,02 % | 31/12/2025 | 3 103 ( 0,02 % ) | 182 941 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GUBRA A/S | Directeur Financier/CFO | 01/08/2022 |
Ascelia Incentive AB | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ASCELIA PHARMA AB | Directeur Financier/CFO | 01/09/2022 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | 01/09/2017 |
| ORSTED A/S | Public Communications Contact | 01/07/2016 |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Investor Relations Contact | 01/07/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Ørsted A/S
Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Utilities |
Ascelia Pharma AB
Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ascelia Incentive AB |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national